Stanford Reports 37,000-Agent Virtual Biotech System
A large-scale multi-agent AI system simulating a biotech company could accelerate AI-driven biological research and dual-use risk.
A large-scale multi-agent AI system simulating a biotech company could accelerate AI-driven biological research and dual-use risk.
Auto-scored: A 37,000-agent virtual biotech system represents a notable capability jump with potential dual-use implications, though no documented misuse or weaponization is reported.